相关实验视频
Updated: Jun 27, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
在流行病学和临床试验研究中的竞争风险和多变量结果
1Fred Hutchinson Cancer Center, 1100 Fairview Ave N., Seattle, WA, 98109, USA. rprentic@WHI.org.
Lifetime data analysis
|May 6, 2024
概括
本研究引入了针对具有竞争风险的临床结果的新数据分析方法,重点关注可识别的边际危险率. 这些方法提高了生存功能的估计,以获得更好的临床研究见解.
科学领域:
- 生物统计学 生物统计学
- 临床流行病学临床流行病学
- 生存分析的分析.
背景情况:
- 由于假设的推断目标,分析具有竞争风险的临床结果具有挑战性.
- 现有的方法通常需要对数据可识别性的强有力的假设.
研究的目的:
- 提出基于对竞争风险的边际危险率的数据分析方法.
- 为临床结果提供可识别的关节存活功能估计器.
主要方法:
- 使用单维和更高维的边际危险率.
- 开发各种临床结果的关节生存功能估计器.
- 将方法应用于模拟和妇女健康倡议数据.
主要成果:
- 在独立审查下证明了边际危险率的识别能力.
- 用模拟和现实世界的数据来说明开发方法的应用.
- 提供了解决临床研究中复杂数据分析问题的基础.
结论:
- 基于边际危险率的方法为竞争性风险分析提供了可识别的解决方案.
- 这些方法改善了临床和队列研究的生存功能估计.
- 需要进一步的研究来扩大这些技术的应用和理解.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Confounding in Epidemiological Studies
164
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
164
Introduction to Epidemiology
720
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
720
Causality in Epidemiology
395
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
395
Strategies for Assessing and Addressing Confounding
93
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
93
Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115

